title: Nitazoxanide in the treatment of chronic cutaneous leishmaniasis resistant to traditional sodium stibogluconate.
authors.forename: Johnny
authors.initials: J
authors.lastname: Gurgen
authors.forename: Daniel
authors.initials: D
authors.lastname: Hogan
authors.forename: Edward
authors.initials: E
authors.lastname: Grace
authors.forename: David
authors.initials: D
authors.lastname: Johnson
mesh_terms: D000284:Administration, Oral; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use; D000977:Antiparasitic Agents / Q000627:therapeutic use*; D001707:Biopsy, Needle; D004334:Drug Administration Schedule; D004351:Drug Resistance; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007262:Infusions, Intravenous; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D009574:Nitro Compounds; D019233:Retreatment; D012720:Severity of Illness Index; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000977:Antiparasitic Agents; D009574:Nitro Compounds; D013844:Thiazoles; C041747:nitazoxanide; D000967:Antimony Sodium Gluconate